MedPath

Comparison of efficacy of low vs high dose of Atorvastatin and Rosuvastatin in reducing 50% LDL in diabetic patient

Phase 2
Recruiting
Conditions
Diabetes melitus.
Type 1 diabetes mellitus,Type 2 diabetes mellitus
E10 , E11
Registration Number
IRCT20180929041169N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Diabetic patient who need to receive Statin according to ADA 2018

Exclusion Criteria

Pregnancy
Patients of Genetic Disease
Use of other lowering agent other than Statin
Hx of Angina
Hx of Nephropathy
Hx of Hypothyroidism
Hx of liver Dx or ALT> 3 ULN,AST>3 ULN
CPK> 10 ULN
Patients on Corticosteroids
Patients with Cyclosporins or Hormone replacement therapy
Hx of use of alcohol

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurment of levels of Low Density lipoprotein. Timepoint: At the initial and 2 month after medication used. Method of measurement: Method of Photometric.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath